bioRxivSynthetic BiologyPreprint
A Scalable Design for Proximity-Inducing Molecules
Endri KarajiD, Varsha Venkatarangan, Shaimaa H. SindiiD, Surached SiriwongsupiD, Chaiheon Lee, Rajaiah PerguiD, Vedagopuram SreekanthiD, Karishma KailassiD, Kien TraniD, Prashant Kumar SinghiD, Sameek SinghiD, Junya KawaiiD, Jeffrey E. Fung, Mahilet Tefera, Rohil DhaliwaliD, Santosh Kumar ChaudharyiD, April Keyes, Ananthan SadagopaniD, Lisa M. BoatneriD, Neel H. ShahiD, Charlie FehliD, Keriann M. BackusiD, Amit ChoudharyiD
Abstract
Chimeric molecules, which bring together an effector enzyme and a protein-of-interest (POI) to add/remove post-translational modifications (PTMs), are furnishing transformative modalities (e.g., PROTACs). However, these chimeras scalability is limited as they employ rare, non-inhibitory binders of effectors. We report GRoup-transfer chimeras for Inducing Proximity (GRIPs) that employ abundantly available effectors inhibitors to append POI binder on the effector using group-transfer handles. To demonstrate scalability, we develop 6 GRIPs classes for 3 PTMs utilizing diverse inhibitor, spanning 16 effector-POI pairs. Furthermore, we report a toolbox of 42 tunable group-transfer handles for Cys/Lys residues and [~]5000 inhibitor-residue pairs for diverse effectors. Using global proteomics, we confirm the specificity for group transfer and PTM editing. GRIPs endowed new functionalities to POI drugs, including preventing rebound signaling upon drug withdrawal, a more potent/persistent inhibition, and inhibitor-induced pathway activation in 4 fully-endogenous systems. In diverse hemi-endogenous systems (tagged POI), GRIPs induced condensate formation with reduced off-targets, cleared pathogenic PTMs, and initiated PTM crosstalk. Overall, GRIPs provide a scalable and versatile platform for PTM editing. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=184 SRC="FIGDIR/small/706349v1_ufig1.gif" ALT="Figure 1"> View larger version (41K): org.highwire.dtl.DTLVardef@132f70dorg.highwire.dtl.DTLVardef@f9aa62org.highwire.dtl.DTLVardef@12143edorg.highwire.dtl.DTLVardef@f296d4_HPS_FORMAT_FIGEXP M_FIG C_FIG
- assay: proteomics
- research focus: drug response / drug discovery
- research focus: protein structure prediction
- research focus: protein design
- approach: experimental assay
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Modular Platform for Effector Discovery in Induced-Proximity Lysine Acetylation
Brianna Hill-Payne, Mohd Younis Bhat, George M. Burslem·bioRxiv·Mar 13, 2026
- Development and applications of chimera platforms for tyrosine phosphorylation
R. Pergu, V. M. Shoba, … A. Choudhary·bioRxiv·Mar 5, 2023
- The NanoBridge system for targeted post-translational modification of challenging proteins
Fangfang Shen, Olga D. Merino-Chavez, … Laura M. K. Dassama·bioRxiv·Jun 10, 2026
- Multiplex design and discovery of proximity handles for programmable proteome editing
Chase C. Suiter, Green Ahn, … Jay Shendure·bioRxiv·Oct 13, 2025
- Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics
Y. V. Serebrenik, D. Mani, … O. Shalem·bioRxiv·Jul 13, 2023
- Identification of actionable targeted protein degradation effector sites through Site-specific Ligand Incorporation-induced Proximity (SLIP)
Zhangping Xiao, Efthymios-Spyridon Gavriil, … Edward W. Tate·Journal of the American Chemical SocietyPeer-reviewed·Jun 10, 2025